Extractive Spectrophotometric Determination of Amitriptyline Hydrochloride in Pure and Pharmaceutical Formulations
K. C. Srinivasa Murthy
Department of Chemistry, Sri Venkateshwara College of Engineering, Vidyanagar, Bengaluru International Airport Road, Bengaluru - 562 157, India.
Article Received on :
Article Accepted on :
Article Published : 31 Dec 2012
A sensitive, reproducible and accurate spectrophotometric method has been developed for determining amitriptyline hydrochloride (ATH) from its pharmaceutical formulation based on solvent extraction into chloroform of the product formed with 1, 2-naphthoquinon-4-sulphonate. The reaction and extraction was complete and quantitative at pH 1.3. The Beer’s law of yellow colored species is obeyed in the range of concentration of 2 – 18 µg ml×-1 at the maximum absorption of 450 nm. The molar absorptivity and Sandell’s sensitivity values were found to be of 3.2382 x 103l mol-1cm-× and 0.9615 µg cm-2 respectively. The results compare favourably with those of official methods. The method is successfully employed for the determination of ATH in pharmaceutical preparations.
KEYWORDS:Amitriptyline hydrochloride; spectrophotometry; 1; 2-naphthoquinon-4-sulphonate
Download this article as:Copy the following to cite this article: Murthy K. C. S. Extractive Spectrophotometric Determination of Amitriptyline Hydrochloride in Pure and Pharmaceutical Formulations. Orient J Chem 2012;28(4). |
Copy the following to cite this URL: Murthy K. C. S. Extractive Spectrophotometric Determination of Amitriptyline Hydrochloride in Pure and Pharmaceutical Formulations. Available from: http://www.orientjchem.org/?p=22887 |
Introduction
Amitriptyline hydrochloride (ATH) is chemically, 3-(10,11-Dihydro-5H-dibenzo [a, d] cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine 1. It is a tricyclic antidepressant used in case of anxiety and also shows anticholinergic, antihistamine and antiserotonimic effects 2. In view of their importance, considerable work has been done on their detection and quantification. Methods used for the determination of ATH include atomic absorption spectroscopic 3, high-performance liquid chromatography 4, 5 and spectrophotometry 6 – 9.The purpose of this study was to determine ATH by simple, accurate, and precise spectrophotometric assays for routine analysis.
The investigator has been able to develop an accurate and sensitive extractive method employing 1, 2-naphthoquinon-4-sulphonate (NQS) in acidic media for the determination of ATH in a bulk sample and its formulation.
Material and Methods
Apparatus
All spectral measurements were made on Shimadzu Double-Beam Spectrophotometer UV-1500-02 with 1.0 cm matched quartz cells.
Reagent
All of the chemicals used were of either pharmaceutical analytical grade. A standard solution of ATH was prepared by dissolving a requisite amount of ATH in distilled water.It was diluted as and when required. A 0.5 % w/v solution of NQS was freshly prepared and protected from sunlight. Buffer of pH 1.0, 1.3 (potassium chloride – hydrochloric acid), 4.0 (potassium hydrogen phthalate – hydrochloric acid) and 4.6 (potassium hydrogen phthalate – sodium hydroxide) were prepared in distilled water.
Procedure
Aliquot of standard solution of ATH (20 – 180 µg ml-1) was transferred into a series of separating funnels. To each funnel, 5 ml of 0.5 % NQS solution and 1.0 ml of buffer solution (pH 1.3) solution were added.Ten ml of chloroform was added to each funnel.The contents were shaken vigorously and left at room temperature for two minutes.The phases were allowed to separate and the chloroform layer passed through anhydrous sodium sulphate. Absorbance values of the chloroform layers were measured at 450 nm against reagent blank.A calibration graph was constructed.
Twenty tablets were powdered and equivalent to 25 mg of the ATH was weighed accurately and transferred into a 100 ml volumetric flask and then volume made up with distilled water and filtered. Appropriate aliquot of the ATH solution was taken and treated as described above for the determination of ATH.
Results and Discussion
Optimum conditions for product formation
It was found that 0.5 % concentration of NQS in the range 4 – 6 ml. Hence, 5.0 ml of NQS and 1.0 ml buffer solution were selected. The buffer solution of pH 1.0, 1.3, 4.0 and 4.6 were used to extract the product. The results are found that 0.5 – 1.5 ml buffer solution of pH 1.3 was necessary for the achievement of maximum color intensity.
Benzene, carbon tetrachloride, 1, 2-dichloromethane, dichloroethane and chloroform were tested as extractive solvents for the proposed reaction. Chloroform was preferred to others for its selective extraction of the colored product. It offers advantages, such as being economically cheaper and convenient, to be used as extractive solvent.
The reaction between ATH and NQS was found to be instantaneous and yellow color produced was stable only 30 minutes. The buffer solution enhances of the stability of color more than 2 hours at 25 ± 3 C°. The effects of temperature on the product were studied at different temperatures.The color product was stable in the temperature range 0.0 – 35 C°.At higher temperatures the drug concentration was increased on prolonged heating due to volatile nature of chloroform. As a result, the absorbance values of the colored products were increased.
Analytical features
The method obeyed Beer’s law in the concentration range of 2 – 18 µg ml-1 with molar absorptivity, specific absorptivity and Sandell’s sensitivity values of 3.2382 x 103 l mol-1 cm-1, 0.0104 ml g-1 cm-1 and 0.9615 µg cm-2 respectively. A regression analysis of a Beer’s law plot at 450 nm revealed a good correlation (r = 0.9960).The graph of the absorbance versus the concentration of ATH showed a low intercept (b = 0.0064) and slope (a = 0.0097) and is described by a regression equation, Y= aX + b (where X is the concentration of ATH in µg ml-1, Y is the absorbance of a 1 cm layer, ‘a’ is the slope and ‘b’ is the intercept). The low relative standard deviation (0.91 %) and the range of error at 95 % confidence level (0.67) for the analysis of five replicates of 10 µg ml-1 indicated good precision and the accuracy of the proposed method.
Interference studies
In order to assess the possible analytical application of the proposed method, the effect of some foreign substances that often accompany ATH in various pharmaceutical products were studied by adding different amounts of substances to 10 µg ml-1 of ATH. An attractive feature of the method is its relative freedom from interference by the usual tablet diluents and excipients in amounts far in excess of their normal occurrence in pharmaceutical preparation.The results are given in Table 1.
Table 1: Determination of 10 µg ml-1 of ATH in the presence of excipients and other substances
Interfering substance |
Amount taken / mg |
Recovery ATH ± % RSDa
|
Lactose Dextrose Starch Talc Glucose Gelatin |
30 30 30 40 30 20 |
9.94 ± 0.88 9.89 ± 0.94 9.93 ± 0.78 9.98 ± 0.82 9.95 ± 0.86 9.96 ± 0.91 |
Application of method
The applicability of the proposed method was examined as an assay of pharmaceutical preparations. The results of the assay of ATH tablets are summarized in Table 2. These results were reproducible. The results of the assay of tablets were crosschecked by the official method10
Table 2: Determination of ATH in pharmaceutical preparation
Drug trade name |
Label claim (mg) |
Recovery of ATH (mg) ± % RSD a
|
|
Proposed method |
Reported Method
|
||
Tryptacareb Amiconc
Amitripd |
50 25 25 |
49.98 ± 0.78 24.99 ± 0.67 25.01 ± 0.59 |
49.97 ± 0.81 24.94 ± 0.72 24.99 ± 0.68 |
Average of five determinations
Marketed by Symbiosis
Marketed by Icon
Marked by Eastwest
Conclusion
The results clearly indicate that the utility of the proposed method for the analysis of ATH in pure and dosage forms. The applicability of the method for the assay of ATH in pharmaceutical preparations has been well demonstrated. Further, assaying authentic samples containing ATH as well as common additives and excipients tests the effect of interfering substances. Thus it can be concluded that this method could be considered for the assay of both bulk and formulation.
Referemces
- O’Neil MJ. The Merck Index. 14th Ed. Whitehouse Station: Merck & Co. Inc.; 2006. Pp. 487–2099.
- Mishra L. Drugs Today. Vol. 1. Delhi: Lorina Publications; 2006. Apr-Jun. Pp. 472–9.
- Elnemma E. M., Elzawawy F.M. And Hassan, S. M., Microchimicaacta, 110 (13) 79 -88 (1993).
- Deshmane GV, Vakil JR, Dhahneshwar SR, Mahadik KR, Kadam SS. Indian Drugs, 34, 443-445 (1997).
- Gandhi R, Sharma P, Chawla HPS, Kaul CL, Panchagnula R. S.T.P. Pharma Sci., 10, 234-238 (2000).
- Reynolds JEF (Ed.), Martindale – The Extra Pharmacopoeia, 30th Ed., The Pharmaceutical Press, London, 8140 (1993).
- Karpinska J, Suszynska J And Trace J. Microprobe Tech., 19, 355-364 (2001).
- Pankajsoni, Santhosh K. S And Rajmani Patel, J. Analytical Sci. Methods And Instrumentation, 2, 103 – 107 (2012).
- Venkatesan P, Subrahmanyam P.V. R. S And Raghu Pratap D, Chem. Tech. 2, 54 -56 (2010)
- Indian Pharmacopoeia. Vol. 2. Ghaziabad: Indian Pharmacopoeia Commission; 2007. Pp. 712–905.
This work is licensed under a Creative Commons Attribution 4.0 International License.